Literature DB >> 25808808

Regulation of MDM2 Stability After DNA Damage.

Jiaqi Li1, Manabu Kurokawa1,2.   

Abstract

Cells in our body are constantly exposed to various stresses and threats to their genomic integrity. The tumor suppressor protein p53 plays a critical role in successful defense against these threats by inducing apoptotic cell death or cell cycle arrest. In unstressed conditions, p53 levels and activity must be kept low to prevent lethal activation of apoptotic and senescence pathways. However, upon DNA damage or other stressors, p53 is released from its inhibitory state to induce an array of apoptosis and cell cycle genes. Conversely, inactivation of p53 could promote unrestrained tumor proliferation and failure to appropriately undergo apoptotic cell death, which could, in turn, lead to carcinogenesis. The ubiquitin E3 ligase MDM2 is the most critical inhibitor of p53 that determines the cellular response to various p53-activating agents, including DNA damage. MDM2 activity is controlled by post-translational modifications, especially phosphorylation. However, accumulating evidence suggests that MDM2 is also regulated at the level of protein stability, which is controlled by the ubiquitin-proteasome pathway. Here, we discuss how MDM2 can be regulated in response to DNA damage with particular focus on the regulation of MDM2 protein stability.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808808      PMCID: PMC5810548          DOI: 10.1002/jcp.24994

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  76 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

Review 3.  Beyond ATM: the protein kinase landscape of the DNA damage response.

Authors:  Ariel Bensimon; Ruedi Aebersold; Yosef Shiloh
Journal:  FEBS Lett       Date:  2011-05-08       Impact factor: 4.124

Review 4.  ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.

Authors:  Erik Meulmeester; Yaron Pereg; Yosef Shiloh; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2005-09-29       Impact factor: 4.534

5.  Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.

Authors:  Domenico Migliorini; Davide Danovi; Emanuela Colombo; Roberta Carbone; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

6.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

7.  MDM2 promotes ubiquitination and degradation of MDMX.

Authors:  Yu Pan; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.

Authors:  Yetao Jin; Shelya X Zeng; Hunjoo Lee; Hua Lu
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

9.  p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK.

Authors:  Karen A Boehme; Roman Kulikov; Christine Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-27       Impact factor: 11.205

10.  Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.

Authors:  Jun Tang; Trisha Agrawal; Qian Cheng; Like Qu; Michael D Brewer; Jiandong Chen; Xiaolu Yang
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more
  18 in total

1.  AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.

Authors:  Anna de Polo; Zhongling Luo; Casimiro Gerarduzzi; Xiang Chen; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

2.  Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.

Authors:  Ina Klusmann; Kai Wohlberedt; Anna Magerhans; Federico Teloni; Jan O Korbel; Matthias Altmeyer; Matthias Dobbelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-09       Impact factor: 11.205

3.  MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

Authors:  Anna de Polo; Varunika Vivekanandan; John B Little; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

4.  Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2.

Authors:  Hyemin Seong; Joo Yeon Jeong; Jinhyun Ryu; Juyeong Park; Yong-Seop Han; Hyun-Kyung Cho; Seong Jae Kim; Jong Moon Park; Sang Soo Kang; Seong Wook Seo
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

5.  MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.

Authors:  Alyssa M Klein; Lynn Biderman; David Tong; Bita Alaghebandan; Sakina A Plumber; Helen S Mueller; Anne van Vlimmeren; Chen Katz; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

Review 6.  Functional roles of E3 ubiquitin ligases in prostate cancer.

Authors:  Yiting Zhao; Jinyun Li; Jun Chen; Meng Ye; Xiaofeng Jin
Journal:  J Mol Med (Berl)       Date:  2022-07-11       Impact factor: 5.606

7.  RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2.

Authors:  Yaqi Chen; Sha Zhou; Kairui Wan; Long Yu; Chongchong Zhao; Haiteng Deng; Qingjian Ou; Jiayi Qin; Junbo Hu; Zhenlin Hou
Journal:  Oncogene       Date:  2022-05-19       Impact factor: 8.756

8.  Inverse association between MDM2 and HUWE1 protein expression levels in human breast cancer and liposarcoma.

Authors:  Kaleigh Canfield; Wendy Wells; Joseph Geradts; William B Kinlaw; Chao Cheng; Manabu Kurokawa
Journal:  Int J Clin Exp Pathol       Date:  2016-06-15

9.  Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.

Authors:  Angel Diaz-Lagares; Ana B Crujeiras; Paula Lopez-Serra; Marta Soler; Fernando Setien; Ashish Goyal; Juan Sandoval; Yutaka Hashimoto; Anna Martinez-Cardús; Antonio Gomez; Holger Heyn; Catia Moutinho; Jesús Espada; August Vidal; Maria Paúles; Maica Galán; Núria Sala; Yoshimitsu Akiyama; María Martínez-Iniesta; Lourdes Farré; Alberto Villanueva; Matthias Gross; Sven Diederichs; Sonia Guil; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 10.  MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy.

Authors:  Xanthene Miles; Charlot Vandevoorde; Alistair Hunter; Julie Bolcaen
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.